Faber Tracy
Known title: EVP & Chief HR OfficerCIK: 0001786045
Associated companies
Transaction History
| MCK | ▼ Sell | Open Market | 90 | $35K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 547 | $215K | 11/8/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 3,647 | $667K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 1,889 | $741K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 1,658 | $652K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 100 | $39K | 11/8/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 835 | $153K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 430 | $167K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 330 | $129K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 40 | $16K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 35 | $14K | 11/8/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 2,893 | $460K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 1,051 | $411K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 879 | $344K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 963 | $378K | 11/8/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 2,811 | $406K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 868 | $338K | 11/8/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 1,853 | $724K | 11/8/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 902 | $0 | 11/4/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 355 | $141K | 11/4/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 5,380 | $1.8M | 5/31/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 2,599 | $868K | 5/27/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 1,564 | $0 | 5/26/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 616 | $207K | 5/26/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 2,185 | $722K | 5/26/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 1,220 | $407K | 5/25/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 1,190 | $0 | 5/25/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 469 | $156K | 5/25/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 3,098 | $0 | 5/25/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 1,433 | $468K | 5/24/2022 | View on chart |
| MCK | ▲ Buy | Grant | 3,356 | $0 | 5/24/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 1,171 | $385K | 5/24/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 2,877 | $946K | 5/24/2022 | View on chart |
| MCK | ▲ Buy | Grant | 7,309 | $0 | 5/24/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 385 | $0 | 5/21/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 94 | $30K | 5/21/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 1,510 | $0 | 5/21/2022 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 368 | $119K | 5/21/2022 | View on chart |
| MCK | ▲ Buy | Option Exercise | 2,034 | $484K | 2/7/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 2,034 | $539K | 2/7/2022 | View on chart |
| MCK | ▼ Sell | Open Market | 8,426 | $1.9M | 11/22/2021 | View on chart |
| MCK | ▼ Sell | Tax Withholding | 355 | $79K | 11/4/2021 | View on chart |
| MCK | ▲ Buy | Option Exercise | 901 | $0 | 11/4/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
McKesson Re-Rated on M&A Momentum Amid Strong Performance
McKesson shares have risen while the broader market fell, driven by renewed analyst interest in the company's increased M&A efforts. This positive sentiment aligns with recent recognition from financial commentators who view the healthcare stock as a strong performer. The stock's strength is further supported by a high RSI, indicating significant recent buying pressure.
McKesson Re-Rated on M&A Momentum Amid Strong Performance. McKesson shares have risen while the broader market fell, driven by renewed analyst interest in the company's increased M&A efforts. This positive sentiment aligns with recent recognition from financial commentators who view the healthcare stock as a strong performer. The stock's strength is further supported by a high RSI, indicating significant recent buying pressure.